CKPT - Checkpoint Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $6.59. This is a potential upside of $2.33 (54.69%) from yesterday's end of day stock price of $4.26.

Checkpoint Therapeutics's activity chart (see below) currently has 16 price targets and 28 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.83% with an average time for these price targets to be met of 46.5 days.

Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 31-Mar-2025. First documented stock forecast 29-May-2019.

Best performing analysts who are covering CKPT - Checkpoint Therapeutics:

Thomas Flaten Joseph Pantginis Jennifer Kim Jason Kolbert

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Jan-2025

$4.8

$0.54 (12.68%)

$4.8

1 years 6 days ago
(31-Mar-2025)

0/3 (0%)

$0.76 (18.81%)

Buy Since 13-Aug-2024

$4.1

$-0.16 (-3.76%)

1 years 26 days ago
(11-Mar-2025)

1/2 (50%)

$0.1 (2.50%)

45

Buy Since 29-May-2019

$4.1

$-0.16 (-3.76%)

$7

1 years 27 days ago
(10-Mar-2025)

2/5 (40%)

$0.12 (3.02%)

117

Buy Since 26-Jan-2022

2 years 7 months 22 days ago
(15-Aug-2023)

1/3 (33.33%)

$8.34 (125.23%)

24

Show more analysts

Please expand the browser size to see the chart

What is CKPT (Checkpoint Therapeutics) average time for price targets to be met?

On average it took 46.5 days on average for the stock forecasts to be realized with a an average price target met ratio 30.83

Which analyst has the current highest performing score on CKPT (Checkpoint Therapeutics) with a proven track record?

THOMAS FLATEN

Which analyst has the current lower performing score on CKPT (Checkpoint Therapeutics) with a proven track record?

JASON KOLBERT

Which analyst has the most public recommendations on CKPT (Checkpoint Therapeutics)?

Thomas Flaten works at LAKE STREET and has 5 price targets and 4 ratings on CKPT

Which analyst is the currently most bullish on CKPT (Checkpoint Therapeutics)?

Jason Kolbert with highest potential upside - $0.54

Which analyst is the currently most reserved on CKPT (Checkpoint Therapeutics)?

Thomas Flaten with lowest potential downside - -$0.16

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?